Presentation TCT 2025 TCT 988: Predictors of Heart Failure Hospitalization Events Following TTVR: Analysis from the Pooled TRISCEND Study and TRISCEND II Trial Presenter: Anna Sannino October 26, 2025
Presentation TCT 2025 TCT 12: Comorbidity of Rheumatic Heart Disease and Heart Failure in the United States: Trends in Prevalence, Hospitalizations, and Public Health Disparities (1999–2023) Presenter: Ahmed Elmorsy Mohamed October 25, 2025
Presentation NY Valves 2025 Impact of Prior History of Hospitalization for Heart Failure on Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis Presenter: Ogechukwu Samuel Obi June 26, 2025
Presentation THT 2025 Subcutaneously Implanted Sensor for Remote Monitoring of Congestive Heart Failure Enables Effortless Capture of Electrocardiography and Three-Axis Acceleration Traces (ECG/SCG) Before and After Hospitalization: First Trend Results in Patients Presenter: Marat Fudim February 13, 2025
Presentation THT 2025 Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification Presenter: Kivanc Ozonat February 12, 2025
Presentation THT 2025 Impact of Prior Heart Failure Hospitalizations on Long-Term Outcomes Following ICD Implantation and Generator Exchange Presenter: Midori Torpoco Rivera February 12, 2025
Presentation THT 2025 Initial Diuretic Strategies and Heart Failure Hospitalization Outcomes: Insights From a Nationwide Community-Based Cohort Presenter: Anubodh Varshney February 12, 2025
Presentation THT 2025 Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization Presenter: JoAnn Lindenfeld February 12, 2025
Presentation THT Abstracts 2025 Bioelectrical Phase Angle for Heart Failure (HF) Hospitalization and Readmission Risk Stratification Presenter: Kivanc Ozonat February 11, 2025
Presentation TCT 2024 TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy Presenter: Stephen Ellis October 29, 2024
Presentation TCT 2024 TCT 639: Immediate Reduction in Left Ventricular Contractility After Mitral Transcatheter Edge-to-Edge Repair Is Associated With Lower Rates of Heart Failure Hospitalizations Presenter: KE WEI CHEN October 28, 2024
Presentation TCT 2024 TCT 625: A Lower Ratio of Regurgitant Volume to Left Atrium Volume Is Associated With a Higher Incidence of Heart Failure Hospitalization in Patients With Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair Presenter: Masafumi Yoshikawa October 28, 2024
Presentation TCT 2024 Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2 Presenter: Ralph von Bardeleben October 27, 2024
Presentation THT 2024 Remote Management of Sitting Pulmonary Artery Pressures Tested Against a Performance Goal of Reduced HF Hospitalizations and All-cause Mortality in a Prospective Multi-Center Open Label PROACTIVE-HF Trial in NYHA Class III Heart Failure Presenter: Liviu Klein March 05, 2024
Presentation THT 2024 Future HF Trials Should Focus on Patients in the High-Risk Period After an ADHF Hospitalization Presenter: Gad Cotter March 04, 2024
Presentation THT 2023 Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life? Presenter: Michael Sutherland March 21, 2023
Presentation THT 2023 Cardiovascular Hospitalization Rates in ATTR-CA: What Factors Make a Difference Presenter: Margaret Cuomo March 21, 2023
Presentation THT 2023 What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design Presenter: William Abraham March 20, 2023
Presentation THT 2022 Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial Presenter: Akshay Desai February 02, 2022
Presentation THT 2022 SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients Presenter: Shashank Sinha February 02, 2022